The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Aug. 13, 2019
Applicant:

Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.o.c., Taoyuan, TW;

Inventors:

Ming-Cheng Chang, Taoyuan, TW;

Tsai-Yueh Luo, Taoyuan, TW;

Cheng-Liang Peng, Taoyuan, TW;

Kuan-Yin Chen, Taoyuan, TW;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/127 (2006.01); A61K 9/107 (2006.01); A61K 31/165 (2006.01); A61K 47/36 (2006.01); A61K 47/42 (2017.01); A61K 47/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 9/1075 (2013.01); A61K 9/127 (2013.01); A61K 9/1277 (2013.01); A61K 31/165 (2013.01); A61K 47/12 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01);
Abstract

The present invention provides an ophthalmic gel and a preparation method thereof. The ophthalmic gel comprises: an antibiotic; a nanocarrier, wherein the nanocarrier is used to load the antibiotic; and a biodegradable matrix, wherein the biodegradable matrix is compatible with the nanocarrier to carry the nanocarrier. When the ophthalmic gel of the present invention is applied to the surface of the cornea and conjunctiva of the eyes, the biodegradable matrix is automatically degraded and the nanocarrier carried by the biodegradable matrix will slowly release the antibiotic, loaded in the nanocarrier, at an appropriate rate to overcome the high-frequency use of general ophthalmic drugs and easily caused blurred vision; the present invention further comprises an ophthalmic gel preparation method.


Find Patent Forward Citations

Loading…